COVID-19: Federal government buys antibody drug developed by Vancouver company

  • 📰 VancouverSun
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 61%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

The Canadian government has agreed to buy 26,000 doses of bamlanivimab, developed by Vancouver\u0027s AbCellera Biologics in partnership with U.S. pharmaceutical company Eli Lilly, for $32.5 million US.

The government will buy 26,000 doses of the drug over a three-month period from December to February for $32.5 million US, according to a news release from Eli Lilly Tuesday.

Bamlanivimab is designed to block viral attachment and entry into human cells, neutralizing the virus and potentially treating COVID-19, according to the company. The U.S. Food and Drug Administration granted emergency-use authorization for bamlanivimab on Nov. 9. Lilly anticipates manufacturing one million doses before the end of the year, and has already reached a deal with the U.S. government for 300,000 doses.

AbCellera researchers used a blood sample from one of the earliest COVID-19 survivors from the U.S. to get their work started.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

WTH_Canada So we don't have domestic capacity for vaccines and will have to wait. We're committed to buy 414M doses of vaccines out of country. But we are only prepared to buy 26,000 doses of a domestic therapeutic and keep some of the money in Canada? Bad headline.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 49. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인